Mobile Trading

STRIDES PHARMA SCIENCE LTD.

NSE : STARBSE : 532531ISIN CODE : INE939A01011Industry : Pharmaceuticals & DrugsHouse : Private
BSE886.202.65 (+0.3 %)
PREV CLOSE ( ) 883.55
OPEN PRICE ( ) 897.95
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 12357
TODAY'S LOW / HIGH ( )870.10 897.95
52 WK LOW / HIGH ( )530.7 1675.25
Select year
ParticularsMar2024Mar2023Mar2022Mar2021Mar2020
Operational & Financial Ratios
   Earnings Per Share (Rs)-7.68-22.44-51.2529.934.06
   CEPS(Rs)7.851.37-26.8750.1924.23
   DPS(Rs)2.501.500.002.5014.00
   Book NAV/Share(Rs)230.95242.83262.48309.09281.55
   Tax Rate(%)-27.0119.3227.3211.4920.71
Margin Ratios
   Core EBITDA Margin(%)11.736.17-0.4011.4510.95
   EBIT Margin(%)3.16-0.40-8.937.774.47
   Pre Tax Margin(%)-1.87-4.58-12.255.031.16
   PAT Margin (%)-2.38-3.70-8.904.450.92
   Cash Profit Margin (%)1.150.20-4.538.224.61
Performance Ratios
   ROA(%)-2.49-3.52-6.993.820.63
   ROE(%)-6.88-10.15-18.499.211.68
   ROCE(%)4.15-0.49-9.499.084.06
   Asset Turnover(x)1.050.950.780.860.68
   Sales/Fixed Asset(x)2.021.911.752.041.43
   Working Capital/Sales(x)69.6543.06-106.8869.38-27.04
Efficiency Ratios
   Fixed Capital/Sales(x)0.500.520.570.490.70
   Receivable days71.2873.2579.4168.0974.33
   Inventory Days66.3667.8081.3566.1364.17
   Payable days204.02230.40267.95264.54274.24
Valuation Parameters
   PER(x)0.000.000.0028.2179.39
   PCE(x)99.68209.18-12.9016.8313.31
   Price/Book(x)3.391.181.322.731.15
   Yield(%)0.320.520.000.304.34
   EV/Net Sales(x)2.321.371.862.861.68
   EV/Core EBITDA(x)12.039.6951.0913.848.11
   EV/EBIT(x)47.67-201.23-12.0122.3221.93
   EV/CE(x)2.071.010.851.390.77
   M Cap / Sales1.780.701.012.281.05
Growth Ratio
   Net Sales Growth(%)9.8320.13-7.4120.4926.33
   Core EBITDA Growth(%)50.42365.23-83.7020.61100.96
   EBIT Growth(%)888.1894.73-211.81102.2448.50
   PAT Growth(%)35.6751.31-294.53462.28-51.42
   EPS Growth(%)65.7656.22-271.23636.70-88.79
Financial Stability Ratios
   Total Debt/Equity(x)1.141.271.180.760.78
   Current Ratio(x)1.031.050.991.030.93
   Quick Ratio(x)0.640.670.640.590.62
   Interest Cover(x)0.63-0.10-2.692.841.35
   Total Debt/Mcap(x)0.341.070.900.280.68

Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020.

Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge.

Pay 20% upfront margin of the transaction value to trade in cash market segment.

Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard.

Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month.
.......... Issued in the interest of Investors

INVESTOR CHARTER
© 2018 Ratnakar Securities Pvt. Ltd. All rights reserved.
Designed, Developed & Content Powered by  Accord Fintech Pvt. Ltd.
CLOSE X

Filing complaints on SCORES Easy & quick

  • > Register on SCORES portal (link:https://scores.gov.in)
  • > Mandatory details for filing complaints on SCORES
    • Name
    • PAN
    • Address
    • Mobile Number
    • E-mail ID
  • > Benefits:
    • Effective communication
    • Speedy redressal of the grievances
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.